The Biologicals Regulation market is a subset of the biopharmaceuticals industry, which focuses on the development and production of biological drugs. Biologicals are drugs derived from living organisms, such as proteins, nucleic acids, and microorganisms. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. The Biologicals Regulation market is responsible for ensuring the safety and efficacy of these drugs, as well as their quality and consistency. This is done through the implementation of regulatory frameworks, such as Good Manufacturing Practices (GMPs) and Good Clinical Practices (GCPs).
Some of the major players in the Biologicals Regulation market include Merck & Co., Pfizer, Novartis, Sanofi, and GlaxoSmithKline. Other companies in the market include Amgen, Bristol-Myers Squibb, Johnson & Johnson, and AstraZeneca. Show Less Read more
